Cryo-ultrasound Versus LASER Therapy on Ankle Sprain in Tennis Players

NCT ID: NCT06766318

Last Updated: 2025-01-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-02-09

Study Completion Date

2024-10-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

the effect cryo-ultrasound therapy and LASER therapy on the short-term recovery of tennis players with acute lateral ankle sprains.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Acute lateral ankle sprains are common injuries among athletes, but the optimal treatment strategies in elite athletes are still debated. This proof-of-concept study aimed to assess the impact of cryo-ultrasound therapy and LASER therapy on the short-term recovery of tennis players with acute lateral ankle sprains.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ankle (Ligaments); Instability (Old Injury)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

OTHER

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

cryo-ultrasound group (n = 20): received cryo-ultrasound therapy

received cryo-ultrasound therapy combined with conventional physical therapy

Group Type EXPERIMENTAL

group A will receive cryo-ultrasound therapy combined with conventional physical therapy for two months

Intervention Type DEVICE

Cryo-ultrasound therapy combines two therapeutic methods: cryotherapy (using cold) and ultrasound (using sound waves). The ultrasound component provides a therapeutic heating effect, improving blood circulation and tissue flexibility, while the cold component reduces pain and inflammation

Laser group

receive LASER therapy combined with conventional physical therapy

Group Type EXPERIMENTAL

LASER therapy

Intervention Type DEVICE

group B will receive LASER therapy combined with conventional physical therapy.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

group A will receive cryo-ultrasound therapy combined with conventional physical therapy for two months

Cryo-ultrasound therapy combines two therapeutic methods: cryotherapy (using cold) and ultrasound (using sound waves). The ultrasound component provides a therapeutic heating effect, improving blood circulation and tissue flexibility, while the cold component reduces pain and inflammation

Intervention Type DEVICE

LASER therapy

group B will receive LASER therapy combined with conventional physical therapy.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ranged from 12-16 years.
* elite girls;
* semi-professional tennis players;
* I-II grade lateral ankle sprain injury;
* no persistent instability phenomena or chronic sprains;
* acute injury (within 2 weeks from trauma);
* no evidence of bone edema or skin disorder, once the area of intense pain in motion was delimited, the lack of neurological disturbances was investigated and assessed.

Exclusion Criteria

* history of recurrent dislocation of the ankle or hyperlaxity of any joint;
* severe rheumatic diseases and/or collagen diseases;
* athletes who have received any form of local physical therapy and NSAIDs within the last 2 months prior to injury;
* athletes who admit to using steroids;
* any contraindication and/or limitation to the use of a physical agent modality (implantable electrophysiological devices, active neoplasms). Taking medications.
* Athletic adult.
Minimum Eligible Age

12 Years

Maximum Eligible Age

16 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

October 6 University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Kerolous Ishak Shehata

Assistant professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kerolous Ishak Kelini, PHD

Role: PRINCIPAL_INVESTIGATOR

AL-Zaytoonah University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cairo University

Cairo, , Egypt

Site Status

Kerolous Ishak Shehata Kelini

Cairo, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

REC/012/005532

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.